Methods and novel technology for microRNA quantification in colorectal cancer screening

[1]  A. Tsapas,et al.  Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis , 2017, JAMA internal medicine.

[2]  Y. Liu,et al.  Circulating miR‐210 as a diagnostic and prognostic biomarker for colorectal cancer , 2017, European journal of cancer care.

[3]  Xiaoli Zhu,et al.  Detection of microRNA: A Point-of-Care Testing Method Based on a pH-Responsive and Highly Efficient Isothermal Amplification. , 2017, Analytical chemistry.

[4]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[5]  O. Shaker,et al.  The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[6]  Hongying Zhang,et al.  Serum MicroRNA profile in patients with colon adenomas or cancer , 2017, BMC Medical Genomics.

[7]  P. Krawczyk,et al.  Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer , 2017, International Journal of Colorectal Disease.

[8]  Ke-Jing Huang,et al.  Au nanoparticles/hollow molybdenum disulfide microcubes based biosensor for microRNA-21 detection coupled with duplex-specific nuclease and enzyme signal amplification. , 2017, Biosensors & bioelectronics.

[9]  Guanghua Chen,et al.  Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer , 2017, Oncotarget.

[10]  M. Stevens,et al.  Multi-Amplified Sensing of MicroRNA by a Small DNA Fragment-Driven Enzymatic Cascade Reaction. , 2017, ACS sensors.

[11]  F. Balaguer,et al.  Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma , 2017, Journal of Translational Medicine.

[12]  Hongjie Dai,et al.  Near-infrared fluorophores for biomedical imaging , 2017, Nature Biomedical Engineering.

[13]  W. Bloch,et al.  Acute Effects of Different Exercise Protocols on the Circulating Vascular microRNAs -16, -21, and -126 in Trained Subjects , 2016, Front. Physiol..

[14]  Leping Li,et al.  The Diagnostic Efficacy and Biological Effects of microRNA-29b for Colon Cancer , 2016, Technology in cancer research & treatment.

[15]  Chunjie Xu,et al.  The diagnostic effect of serum miR-196b as biomarker in colorectal cancer , 2016, Biomedical reports.

[16]  De-Ming Kong,et al.  G-quadruplex fluorescent probe-mediated real-time rolling circle amplification strategy for highly sensitive microRNA detection. , 2016, Analytica chimica acta.

[17]  Jayoung Kim,et al.  Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing , 2016, International neurourology journal.

[18]  Y. Toiyama,et al.  Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  R. Vyzula,et al.  Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer. , 2016, Carcinogenesis.

[20]  Shuang Yu,et al.  Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[21]  M. Ferrari,et al.  Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection , 2016, ACS omega.

[22]  Zongbing Li,et al.  Sensitive detection of miRNA by using hybridization chain reaction coupled with positively charged gold nanoparticles , 2016, Scientific Reports.

[23]  Peng Miao,et al.  A plasmonic colorimetric strategy for visual miRNA detection based on hybridization chain reaction , 2016, Scientific Reports.

[24]  X. Matías-Guiu,et al.  Molecularly determined total tumour load in lymph nodes of stage I–II colon cancer patients correlates with high-risk factors. A multicentre prospective study , 2016, Virchows Archiv.

[25]  Yuguo Tang,et al.  Near-Infrared Ag2S Quantum Dots-Based DNA Logic Gate Platform for miRNA Diagnostics. , 2016, Analytical chemistry.

[26]  J. Švitel,et al.  Optical biosensors , 2016, Essays in biochemistry.

[27]  J. McPherson,et al.  Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.

[28]  Jing Wang,et al.  Fe₃O₄@Ag magnetic nanoparticles for microRNA capture and duplex-specific nuclease signal amplification based SERS detection in cancer cells. , 2016, Biosensors & bioelectronics.

[29]  C. Lawrie,et al.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies , 2016, International journal of molecular sciences.

[30]  Sai Bi,et al.  Triggered and catalyzed self-assembly of hyperbranched DNA structures for logic operations and homogeneous CRET biosensing of microRNA. , 2016, Chemical communications.

[31]  S. Karmakar,et al.  Homo- and Heterobimetallic Ruthenium(II) and Osmium(II) Complexes Based on a Pyrene-Biimidazolate Spacer as Efficient DNA-Binding Probes in the Near-Infrared Domain. , 2016, Inorganic chemistry.

[32]  Q. Wei,et al.  Circulating microRNA-21 as a potential diagnostic marker for colorectal cancer: A meta-analysis. , 2016, Molecular and clinical oncology.

[33]  Yu-Sun Chang,et al.  MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection , 2016, Oncotarget.

[34]  Y. Wang,et al.  Plasma extracellular RNA profiles in healthy and cancer patients , 2016, Scientific Reports.

[35]  W. Tan,et al.  A unique approach toward near-infrared fluorescent probes for bioimaging with remarkably enhanced contrast , 2016, Chemical science.

[36]  Z. Lj,et al.  Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis. , 2015 .

[37]  Jun Yu,et al.  microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer , 2015, Oncotarget.

[38]  C. Fan,et al.  Isothermal Amplification of Nucleic Acids. , 2015, Chemical reviews.

[39]  Y. Chai,et al.  RNA responsive and catalytic self-assembly of DNA nanostructures for highly sensitive fluorescence detection of microRNA from cancer cells. , 2015, Chemical communications.

[40]  J. Yang,et al.  Weight-reduction through a low-fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice , 2015, BMC Genomics.

[41]  S. Elsafi,et al.  The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings , 2015, Clinical and experimental gastroenterology.

[42]  J. Weissfeld,et al.  Differential expression of circulating microRNAs according to severity of colorectal neoplasia. , 2015, Translational research : the journal of laboratory and clinical medicine.

[43]  B. Ye,et al.  Colorimetric detection of sequence-specific microRNA based on duplex-specific nuclease-assisted nanoparticle amplification. , 2015, The Analyst.

[44]  K. Mimori,et al.  Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer , 2015, British Journal of Cancer.

[45]  Aniruddha Chatterjee,et al.  A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients , 2015, Scientific Reports.

[46]  C. Boland,et al.  Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia , 2015, Clinical Cancer Research.

[47]  I. Jacobs,et al.  Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples , 2015, British Journal of Cancer.

[48]  Xin-shu Dong,et al.  The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. , 2015, International journal of clinical and experimental pathology.

[49]  Chuan He,et al.  Live Cell MicroRNA Imaging Using Cascade Hybridization Reaction. , 2015, Journal of the American Chemical Society.

[50]  Hong-bing Chen,et al.  Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer , 2015, Tumor Biology.

[51]  Jun Xiao,et al.  Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis , 2015, Cellular Physiology and Biochemistry.

[52]  C. Dang,et al.  Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer , 2015, Cancer biology & therapy.

[53]  Jinghong Li,et al.  Carbon nanotube enhanced label-free detection of microRNAs based on hairpin probe triggered solid-phase rolling-circle amplification. , 2015, Nanoscale.

[54]  U. Mansmann,et al.  An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology , 2015, Cancer informatics.

[55]  Y. Doki,et al.  Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. , 2014, Oncology reports.

[56]  Chuan Wang,et al.  Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma , 2014, British Journal of Cancer.

[57]  Jun Yu,et al.  microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma , 2014, British Journal of Cancer.

[58]  Hongshan He,et al.  Near-infrared emitting lanthanide complexes of porphyrin and BODIPY dyes , 2014 .

[59]  S. Lawler,et al.  MicroRNAs in cancer: biomarkers, functions and therapy. , 2014, Trends in molecular medicine.

[60]  J. Marshall,et al.  Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review. , 2014, Canadian journal of gastroenterology & hepatology.

[61]  E. Chan,et al.  Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians. , 2014, Oncology reports.

[62]  Mei Zhao,et al.  Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection , 2014, PloS one.

[63]  D. Ransohoff,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[64]  Pratik Shah,et al.  In-solution multiplex miRNA detection using DNA-templated silver nanocluster probes. , 2014, The Analyst.

[65]  Yixuan Hou,et al.  MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.

[66]  Jiye Shi,et al.  Hybridization chain reaction amplification of microRNA detection with a tetrahedral DNA nanostructure-based electrochemical biosensor. , 2014, Analytical chemistry.

[67]  Ru-Qin Yu,et al.  A highly sensitive target-primed rolling circle amplification (TPRCA) method for fluorescent in situ hybridization detection of microRNA in tumor cells. , 2014, Analytical chemistry.

[68]  D. Ahlquist,et al.  Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT) , 2014, PloS one.

[69]  Li Liang,et al.  Isothermally sensitive detection of serum circulating miRNAs for lung cancer diagnosis. , 2013, Analytical chemistry.

[70]  H. Allawi,et al.  Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[71]  Yoshihiro Ito,et al.  Long-lived luminogenic probe for detection of RNA in a crude solution of living bacterial cells. , 2013, Journal of the American Chemical Society.

[72]  Bin Li,et al.  Isothermal amplification method for next-generation sequencing , 2013, Proceedings of the National Academy of Sciences.

[73]  Gordon K Smyth,et al.  The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease , 2013, RNA.

[74]  Chee Woon Wang,et al.  Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer , 2013, BMC Cancer.

[75]  J. Lozano,et al.  Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[76]  Y. Xi,et al.  Challenges for MicroRNA Microarray Data Analysis , 2013, Microarrays.

[77]  Charles J. Kahi,et al.  Screening and surveillance for colorectal cancer: state of the art. , 2013, Gastrointestinal endoscopy.

[78]  C. Foy,et al.  A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability. , 2013, BioTechniques.

[79]  T. Vasaitis,et al.  Phytoalexins, miRNAs and Breast Cancer: A Review of Phytochemical-mediated miRNA Regulation in Breast Cancer , 2013, Journal of health care for the poor and underserved.

[80]  Wei Ren,et al.  Graphene surface-anchored fluorescence sensor for sensitive detection of microRNA coupled with enzyme-free signal amplification of hybridization chain reaction. , 2012, ACS applied materials & interfaces.

[81]  Kshitij Srivastava,et al.  Comprehensive Review of Genetic Association Studies and Meta-Analyses on miRNA Polymorphisms and Cancer Risk , 2012, PloS one.

[82]  E. Olson,et al.  MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles , 2012, Nature Reviews Drug Discovery.

[83]  Ye Sun,et al.  Rapid and direct microRNA quantification by an enzymatic luminescence assay. , 2012, Analytical biochemistry.

[84]  T. Stukel,et al.  Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  M. Pfaffl,et al.  Profound Effect of Profiling Platform and Normalization Strategy on Detection of Differentially Expressed MicroRNAs – A Comparative Study , 2012, PloS one.

[86]  J. Wan,et al.  Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. , 2012, World journal of gastroenterology.

[87]  T. Ried,et al.  A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps , 2012, Genes, chromosomes & cancer.

[88]  D. Kang,et al.  Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer , 2012, PloS one.

[89]  Shahram Hejazi,et al.  Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers. , 2012, Chemistry of materials : a publication of the American Chemical Society.

[90]  Seena K. Ajit.  Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules , 2012, Sensors.

[91]  Yu-Qiang Liu,et al.  One-step, multiplexed fluorescence detection of microRNAs based on duplex-specific nuclease signal amplification. , 2012, Journal of the American Chemical Society.

[92]  A. Tijsen,et al.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.

[93]  Hongshan He,et al.  Iodized BODIPY as a long wavelength light sensitizer for the near-infrared emission of ytterbium(III) ion. , 2012, Chemical communications.

[94]  C. Plass,et al.  Cancer chemoprevention by targeting the epigenome. , 2011, Current drug targets.

[95]  T. Soukka,et al.  Homogeneous detection of avidin based on switchable lanthanide luminescence. , 2011, Analytical chemistry.

[96]  T. Gunnlaugsson,et al.  Recent Highlights in the use of Lanthanide-directed Synthesis of Novel Supramolecular (Luminescent) Self-assembly Structures such as Coordination Bundles, Helicates and Sensors , 2011 .

[97]  Hongshan He,et al.  BODIPY chromophores as efficient green light sensitizers for lanthanide-induced near-infrared emission. , 2011, Dalton transactions.

[98]  Jun Yu,et al.  Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps , 2011, Gut.

[99]  Feng Wang,et al.  Emulsion PCR: A High Efficient Way of PCR Amplification of Random DNA Libraries in Aptamer Selection , 2011, PloS one.

[100]  L. Bisanti,et al.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. , 2011, Journal of the National Cancer Institute.

[101]  G. Federici,et al.  Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer , 2011, Journal of Gastroenterology.

[102]  S. Cirera,et al.  Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers , 2011, BMC biotechnology.

[103]  B. Oliver,et al.  Microarrays, deep sequencing and the true measure of the transcriptome , 2011, BMC Biology.

[104]  Zhengping Li,et al.  One-step ultrasensitive detection of microRNAs with loop-mediated isothermal amplification (LAMP). , 2011, Chemical communications.

[105]  Holger Sültmann,et al.  Serum microRNAs as non-invasive biomarkers for cancer , 2010, Molecular Cancer.

[106]  B. Larsen.  [Colorectal cancer screening]. , 2010, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[107]  Tongyu Lin,et al.  Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.

[108]  A. Neugut,et al.  Colonoscopy vs sigmoidoscopy screening: getting it right. , 2010, JAMA.

[109]  Yongqiang Cheng,et al.  Ultrasensitive detection of microRNAs by exponential isothermal amplification. , 2010, Angewandte Chemie.

[110]  P. Choyke,et al.  New strategies for fluorescent probe design in medical diagnostic imaging. , 2010, Chemical reviews.

[111]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[112]  T. Soukka,et al.  Luminescence switching by hybridization-directed mixed lanthanide complex formation. , 2010, Analytical chemistry.

[113]  Robert B. Hartlage,et al.  This PDF file includes: Materials and Methods , 2009 .

[114]  Timothy D. Harris,et al.  The challenges of sequencing by synthesis , 2009, Nature Biotechnology.

[115]  J. Bünzli,et al.  Surprisingly bright near-infrared luminescence and short radiative lifetimes of ytterbium in hetero-binuclear Yb-Na chelates. , 2009, Inorganic chemistry.

[116]  Gozoh Tsujimoto,et al.  Intra-Platform Repeatability and Inter-Platform Comparability of MicroRNA Microarray Technology , 2009, PloS one.

[117]  T. Gunnlaugsson,et al.  Mixed f-d coordination complexes as dual visible- and near-infrared-emitting probes for targeting DNA. , 2009, Inorganic chemistry.

[118]  W. Ansorge.  Next-generation DNA sequencing techniques. , 2009, New biotechnology.

[119]  B. Gulec,et al.  Persistent High Postoperative Carcinoembryonic Antigen in Colorectal Cancer Patients- Is it Important? , 2009, Clinics.

[120]  J. Houwing-Duistermaat,et al.  IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study , 2009, BMC Medical Genetics.

[121]  Sylvain Pradervand,et al.  Impact of normalization on miRNA microarray expression profiling. , 2009, RNA.

[122]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[123]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[124]  M. Hakama,et al.  Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design , 2008, BMJ : British Medical Journal.

[125]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[126]  K Nikolaou,et al.  Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population , 2008, Gut.

[127]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[128]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[129]  Tetsuo Nagano,et al.  Functional Near‐Infrared Fluorescent Probes , 2008 .

[130]  V. Gebski,et al.  What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[131]  M Westwood,et al.  Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review , 2007, Journal of medical screening.

[132]  M. Duffy,et al.  Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. , 2007, European journal of cancer.

[133]  Jørgen Kjems,et al.  A microRNA detection system based on padlock probes and rolling circle amplification. , 2006, RNA.

[134]  Z. Szallasi,et al.  Reliability and reproducibility issues in DNA microarray measurements. , 2006, Trends in genetics : TIG.

[135]  K. Livak,et al.  Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.

[136]  E. Dekker,et al.  MULTIDISCIPLINARY SYMPOSIUM: COLORECTAL CANCER , 2022 .

[137]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[138]  Robert M. Dirks,et al.  Triggered amplification by hybridization chain reaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Michelle L. Klosterman,et al.  Adherence with colorectal cancer screening guidelines: a review. , 2004, Preventive medicine.

[140]  T. Church,et al.  Colorectal cancer screening adherence in a general population. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[141]  M. Duffy,et al.  Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. , 2003, European journal of cancer.

[142]  Justin C.Y. Wu,et al.  Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. , 2003, Gastroenterology.

[143]  M. Duffy,et al.  Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? , 2001, Clinical chemistry.

[144]  W. Gillin,et al.  980 nm electroluminescence from ytterbium tris(8-hydroxyquinoline) , 2001 .

[145]  V. Pecharsky,et al.  Handbook on the physics and chemistry of rare earths , 1979 .

[146]  Jennifer S Lin,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[147]  M. Zhi,et al.  Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis. , 2015, Genetics and molecular research : GMR.

[148]  Delin Liu,et al.  Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis. , 2015, Cancer biomarkers : section A of Disease markers.

[149]  O. Kranenburg,et al.  The value of miRNA in diagnosing thyroid cancer: a systematic review. , 2012, Cancer biomarkers : section A of Disease markers.

[150]  Jason C Hsu,et al.  A Comparison of Normalization Techniques for MicroRNA Microarray Data , 2008, Statistical applications in genetics and molecular biology.

[151]  J. Bünzli,et al.  Chapter 235 Lanthanide Near-Infrared Luminescence in Molecular Probes and Devices , 2007 .

[152]  Renée X de Menezes,et al.  Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. , 2004, Nucleic acids research.